Articles by Marcia Parker, Ph.D. - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Marcia Parker, Ph.D.

Marcia Parker, Ph.D.


Final Word: Obtaining Government Funding in a Post 9/11/Era
October 1, 2005

The ripple effects of 9/11 are still being felt, creating changes among individuals, businesses, and government organizations. The biotech community is no different; companies are taking a new look at the way they do business and shifting their focuses in response to new opportunities presented by federal preparedness programs. In 2004, President Bush signed "Project BioShield," a bill that made $5.6 billion in federal funds available over a 10-year period to develop countermeasures against chemical, biological, radiological, or nuclear attack. An additional $2.5 billion was added to the initiative in 2005. Numerous grants and contracts have already been awarded to companies developing innovative prophylactic measures, treatments, and diagnostic tools to be used in the event of a biological attack.

ADVERTISEMENT

ADVERTISEMENT

Click here